Genetic and biological variation in equine infectious anemia virus Rev correlates with variable stages of clinical disease in an experimentally infected pony

Michael A. Belshan, Prasith Baccam, J. Lindsay Oaks, Brett A. Sponseller, Sean C. Murphy, James Cornette, Susan Carpenter

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Genetic and biological variation in the regulatory protein Rev of equine infectious anemia virus (EIAV) were examined throughout a clinically dynamic disease course of an experimentally infected pony. Following infection with the virulent EIAVwyo, the pony underwent a variable disease course, including an acute fever episode at 12 days postinfection (DPI), multiple recurrent fever episodes until 135 DPI, a prolonged subclinical period, and two late fever episodes. Viral RNA was isolated from the inoculum and sequential sera samples, and the rev exon 2/gp45 overlapping ORFs were amplified, cloned, and sequenced. Novel variants were found throughout infection, and genetic analyses indicated that both the Rev and gp45 ORFs were under selective pressure. The Rev variant predominant in the inoculum, R1, remained predominant during the early periods following infection (until 35 DPI); however, R1 was replaced by new predominant variants during the recurrent fever period (67-135 DPI). R1 reemerged as the predominant variant during the afebrile period, but a new predominant variant, R93, was associated with the late fever episodes. Rev variants predominant during recurrent febrile and late-febrile periods had significantly higher Rev-mediated nuclear export activity than the variants predominant during the acute and afebrile periods. Statistical correlation was found between Rev activity and different stages of clinical disease. Together, these results suggest that genetic and biological variation in rev may be a contributing factor in EIAV disease progression.

Original languageEnglish
Pages (from-to)185-200
Number of pages16
JournalVirology
Volume279
Issue number1
DOIs
StatePublished - Jan 20 2001
Externally publishedYes

Fingerprint

Equine infectious anemia virus
Fever
Open Reading Frames
rev Gene Products
Infection
Cell Nucleus Active Transport
Viral RNA
Virus Diseases
Disease Progression
Exons

All Science Journal Classification (ASJC) codes

  • Virology
  • Infectious Diseases

Cite this

Genetic and biological variation in equine infectious anemia virus Rev correlates with variable stages of clinical disease in an experimentally infected pony. / Belshan, Michael A.; Baccam, Prasith; Oaks, J. Lindsay; Sponseller, Brett A.; Murphy, Sean C.; Cornette, James; Carpenter, Susan.

In: Virology, Vol. 279, No. 1, 20.01.2001, p. 185-200.

Research output: Contribution to journalArticle

Belshan, Michael A. ; Baccam, Prasith ; Oaks, J. Lindsay ; Sponseller, Brett A. ; Murphy, Sean C. ; Cornette, James ; Carpenter, Susan. / Genetic and biological variation in equine infectious anemia virus Rev correlates with variable stages of clinical disease in an experimentally infected pony. In: Virology. 2001 ; Vol. 279, No. 1. pp. 185-200.
@article{46672477219d44b3ac50e916c8163886,
title = "Genetic and biological variation in equine infectious anemia virus Rev correlates with variable stages of clinical disease in an experimentally infected pony",
abstract = "Genetic and biological variation in the regulatory protein Rev of equine infectious anemia virus (EIAV) were examined throughout a clinically dynamic disease course of an experimentally infected pony. Following infection with the virulent EIAVwyo, the pony underwent a variable disease course, including an acute fever episode at 12 days postinfection (DPI), multiple recurrent fever episodes until 135 DPI, a prolonged subclinical period, and two late fever episodes. Viral RNA was isolated from the inoculum and sequential sera samples, and the rev exon 2/gp45 overlapping ORFs were amplified, cloned, and sequenced. Novel variants were found throughout infection, and genetic analyses indicated that both the Rev and gp45 ORFs were under selective pressure. The Rev variant predominant in the inoculum, R1, remained predominant during the early periods following infection (until 35 DPI); however, R1 was replaced by new predominant variants during the recurrent fever period (67-135 DPI). R1 reemerged as the predominant variant during the afebrile period, but a new predominant variant, R93, was associated with the late fever episodes. Rev variants predominant during recurrent febrile and late-febrile periods had significantly higher Rev-mediated nuclear export activity than the variants predominant during the acute and afebrile periods. Statistical correlation was found between Rev activity and different stages of clinical disease. Together, these results suggest that genetic and biological variation in rev may be a contributing factor in EIAV disease progression.",
author = "Belshan, {Michael A.} and Prasith Baccam and Oaks, {J. Lindsay} and Sponseller, {Brett A.} and Murphy, {Sean C.} and James Cornette and Susan Carpenter",
year = "2001",
month = "1",
day = "20",
doi = "10.1006/viro.2000.0696",
language = "English",
volume = "279",
pages = "185--200",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Genetic and biological variation in equine infectious anemia virus Rev correlates with variable stages of clinical disease in an experimentally infected pony

AU - Belshan, Michael A.

AU - Baccam, Prasith

AU - Oaks, J. Lindsay

AU - Sponseller, Brett A.

AU - Murphy, Sean C.

AU - Cornette, James

AU - Carpenter, Susan

PY - 2001/1/20

Y1 - 2001/1/20

N2 - Genetic and biological variation in the regulatory protein Rev of equine infectious anemia virus (EIAV) were examined throughout a clinically dynamic disease course of an experimentally infected pony. Following infection with the virulent EIAVwyo, the pony underwent a variable disease course, including an acute fever episode at 12 days postinfection (DPI), multiple recurrent fever episodes until 135 DPI, a prolonged subclinical period, and two late fever episodes. Viral RNA was isolated from the inoculum and sequential sera samples, and the rev exon 2/gp45 overlapping ORFs were amplified, cloned, and sequenced. Novel variants were found throughout infection, and genetic analyses indicated that both the Rev and gp45 ORFs were under selective pressure. The Rev variant predominant in the inoculum, R1, remained predominant during the early periods following infection (until 35 DPI); however, R1 was replaced by new predominant variants during the recurrent fever period (67-135 DPI). R1 reemerged as the predominant variant during the afebrile period, but a new predominant variant, R93, was associated with the late fever episodes. Rev variants predominant during recurrent febrile and late-febrile periods had significantly higher Rev-mediated nuclear export activity than the variants predominant during the acute and afebrile periods. Statistical correlation was found between Rev activity and different stages of clinical disease. Together, these results suggest that genetic and biological variation in rev may be a contributing factor in EIAV disease progression.

AB - Genetic and biological variation in the regulatory protein Rev of equine infectious anemia virus (EIAV) were examined throughout a clinically dynamic disease course of an experimentally infected pony. Following infection with the virulent EIAVwyo, the pony underwent a variable disease course, including an acute fever episode at 12 days postinfection (DPI), multiple recurrent fever episodes until 135 DPI, a prolonged subclinical period, and two late fever episodes. Viral RNA was isolated from the inoculum and sequential sera samples, and the rev exon 2/gp45 overlapping ORFs were amplified, cloned, and sequenced. Novel variants were found throughout infection, and genetic analyses indicated that both the Rev and gp45 ORFs were under selective pressure. The Rev variant predominant in the inoculum, R1, remained predominant during the early periods following infection (until 35 DPI); however, R1 was replaced by new predominant variants during the recurrent fever period (67-135 DPI). R1 reemerged as the predominant variant during the afebrile period, but a new predominant variant, R93, was associated with the late fever episodes. Rev variants predominant during recurrent febrile and late-febrile periods had significantly higher Rev-mediated nuclear export activity than the variants predominant during the acute and afebrile periods. Statistical correlation was found between Rev activity and different stages of clinical disease. Together, these results suggest that genetic and biological variation in rev may be a contributing factor in EIAV disease progression.

UR - http://www.scopus.com/inward/record.url?scp=0035916015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035916015&partnerID=8YFLogxK

U2 - 10.1006/viro.2000.0696

DO - 10.1006/viro.2000.0696

M3 - Article

VL - 279

SP - 185

EP - 200

JO - Virology

JF - Virology

SN - 0042-6822

IS - 1

ER -